Ovid Therapeutics (OVID) Cash & Equivalents (2016 - 2026)
Ovid Therapeutics' Cash & Equivalents was $11.33 million in Q2 2026, down 60.1% from $28.42 million a year earlier and down 88.0% from the prior quarter.
Powered by 
Analysis
Ovid Therapeutics (OVID) Cash & Equivalents (2016 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Ovid Therapeutics came in at $13.15 million, down 50.0% from FY2024.
- Cash & Equivalents has now declined for four consecutive years, with a five-year compound annual growth rate of -28.8% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $26.3 million in FY2024 (-2.7%), $27.04 million in FY2023 (-39.7%), $44.87 million in FY2022 (-76.1%) and $187.8 million in FY2021 (+160.7%).
- The Q2 2026 figure marks the lowest quarterly Cash & Equivalents in data going back to Q1 2016.
- Compared with a year earlier, Cash & Equivalents was higher in two of the last eight quarters, with growth averaging 20.0%.
- The best year-over-year quarter for Cash & Equivalents over five years was Q1 2026 (growth of 345.0%); the worst was Q4 2022 (a decline of 76.1%).
- Per Business Quant data, OVID's Cash & Equivalents in the three quarters before Q2 2026 was $94.06 million (Q1 2026), $13.15 million (Q4 2025) and $20.61 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Ovid Therapeutics | 439.72 Mn | 71.74 Mn | - | 11.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.33 Mn |
| Mar 31, 2026 | 94.06 Mn |
| Dec 31, 2025 | 13.15 Mn |
| Sep 30, 2025 | 20.61 Mn |
| Jun 30, 2025 | 28.42 Mn |
| Mar 31, 2025 | 21.14 Mn |
| Dec 31, 2024 | 26.30 Mn |
| Sep 30, 2024 | 15.02 Mn |
| Jun 30, 2024 | 29.69 Mn |
| Mar 31, 2024 | 30.77 Mn |
| Dec 31, 2023 | 27.04 Mn |
| Sep 30, 2023 | 57.44 Mn |
| Jun 30, 2023 | 71.62 Mn |
| Mar 31, 2023 | 63.05 Mn |
| Dec 31, 2022 | 44.87 Mn |
| Sep 30, 2022 | 58.26 Mn |
| Jun 30, 2022 | 72.81 Mn |
| Mar 31, 2022 | 168.60 Mn |
| Dec 31, 2021 | 187.80 Mn |
| Sep 30, 2021 | 201.80 Mn |
API Access
Ovid Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=OVID&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();